Supernus Pharmaceuticals (SUPN) Q1 2017 Earnings

28FebConfirmed
Q1 2016
Q2 2016
Q3 2016
Q1 2017
0.06
0.13
0.2
0.27

Details

Expected EPS
0.27
Actual EPS
0.26
Surprise EPS
-0.01
Surprise Percent
+3.7%

Description

Supernus Pharmaceuticals (SUPN) has reported earnings of 0.26 per share for Q1 2017.

0 Comments

Share your thoughts